Vascular Therapies
Latest round
- Series E
Last raised
- Feb 2015
Total raised
- $21M
Investors
- 1
About Vascular Therapies
Vascular Therapies, Inc.Founded in 2001 and headquartered in Cresskill, US, Vascular Therapies, Inc. specializes in creating solutions for vascular access.96 mn.Vascular Therapies specializes in innovative solutions for improving vascular access in hemodialysis patients. The company’s core product, Sirogen™, is a bioabsorbable implant designed to deliver sirolimus, a drug known to prevent blood vessel narrowing, directly to the site of arteriovenous fistulas. This intervention aims to enhance the usability of fistulas for successful hemodialysis while minimizing the time required for these access points to mature and be ready for use. Additionally, the company addresses significant complications associated with traditional vascular access methods, such as central venous catheters and arteriovenous grafts, by providing options that reduce the risk of infection and thrombosis.S.The revenue structure for Vascular Therapies is centered on the sales of its flagship product, Sirogen™, to healthcare facilities and providers in the dialysis sector. Transactions typically occur through direct sales to hospitals and dialysis clinics, where the product is integrated into surgical procedures involving the creation of arteriovenous fistulas. The company engages in B2B transactions, focusing on partnerships with medical institutions that provide dialysis treatment. Pricing plans for Sirogen™ are based on competitive industry standards for medical implants, reflecting the value provided in enhancing patient outcomes and addressing vascular access challenges.In February 2022, Vascular Therapies, Inc. The company plans to expand its reach by introducing this innovative product to new markets and regions, further enhancing its product offerings for vascular access in hemodialysis.
Who invested in Vascular Therapies
1 investor across 3 rounds
See all investors in Vascular Therapies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vascular Therapies
Who invested in Vascular Therapies?
Vascular Therapies has 1 investor on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vascular Therapies raised?
Vascular Therapies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Vascular Therapies last raise money?
Vascular Therapies's most recent round on record is a Series E, in Feb 2015.
What does Vascular Therapies do?
Vascular Therapies is a biotechnology company.
Where is Vascular Therapies headquartered?
Vascular Therapies is headquartered in Cresskill, US.
Which VCs invest in companies like Vascular Therapies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vascular Therapies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Vascular Therapies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.